These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38753770)

  • 1. mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.
    Xie Z; Lin YC; Steichen JM; Ozorowski G; Kratochvil S; Ray R; Torres JL; Liguori A; Kalyuzhniy O; Wang X; Warner JE; Weldon SR; Dale GA; Kirsch KH; Nair U; Baboo S; Georgeson E; Adachi Y; Kubitz M; Jackson AM; Richey ST; Volk RM; Lee JH; Diedrich JK; Prum T; Falcone S; Himansu S; Carfi A; Yates JR; Paulson JC; Sok D; Ward AB; Schief WR; Batista FD
    Science; 2024 May; 384(6697):eadk0582. PubMed ID: 38753770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
    Steichen JM; Phung I; Salcedo E; Ozorowski G; Willis JR; Baboo S; Liguori A; Cottrell CA; Torres JL; Madden PJ; Ma KM; Sutton HJ; Lee JH; Kalyuzhniy O; Allen JD; Rodriguez OL; Adachi Y; Mullen TM; Georgeson E; Kubitz M; Burns A; Barman S; Mopuri R; Metz A; Altheide TK; Diedrich JK; Saha S; Shields K; Schultze SE; Smith ML; Schiffner T; Burton DR; Watson CT; Bosinger SE; Crispin M; Yates JR; Paulson JC; Ward AB; Sok D; Crotty S; Schief WR
    Science; 2024 May; 384(6697):eadj8321. PubMed ID: 38753769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.
    Wiehe K; Saunders KO; Stalls V; Cain DW; Venkatayogi S; Martin Beem JS; Berry M; Evangelous T; Henderson R; Hora B; Xia SM; Jiang C; Newman A; Bowman C; Lu X; Bryan ME; Bal J; Sanzone A; Chen H; Eaton A; Tomai MA; Fox CB; Tam YK; Barbosa C; Bonsignori M; Muramatsu H; Alam SM; Montefiori DC; Williams WB; Pardi N; Tian M; Weissman D; Alt FW; Acharya P; Haynes BF
    Cell Host Microbe; 2024 May; 32(5):693-709.e7. PubMed ID: 38670093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.
    Ray R; Schiffner T; Wang X; Yan Y; Rantalainen K; Lee CD; Parikh S; Reyes RA; Dale GA; Lin YC; Pecetta S; Giguere S; Swanson O; Kratochvil S; Melzi E; Phung I; Madungwe L; Kalyuzhniy O; Warner J; Weldon SR; Tingle R; Lamperti E; Kirsch KH; Phelps N; Georgeson E; Adachi Y; Kubitz M; Nair U; Crotty S; Wilson IA; Schief WR; Batista FD
    Nat Immunol; 2024 Jun; 25(6):1083-1096. PubMed ID: 38816616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Huang D; Abbott RK; Havenar-Daughton C; Skog PD; Al-Kolla R; Groschel B; Blane TR; Menis S; Tran JT; Thinnes TC; Volpi SA; Liguori A; Schiffner T; Villegas SM; Kalyuzhniy O; Pintea M; Voss JE; Phelps N; Tingle R; Rodriguez AR; Martin G; Kupryianov S; deCamp A; Schief WR; Nemazee D; Crotty S
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22920-22931. PubMed ID: 32873644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles.
    Melo M; Porter E; Zhang Y; Silva M; Li N; Dobosh B; Liguori A; Skog P; Landais E; Menis S; Sok D; Nemazee D; Schief WR; Weiss R; Irvine DJ
    Mol Ther; 2019 Dec; 27(12):2080-2090. PubMed ID: 31515132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.
    Wang X; Cottrell CA; Hu X; Ray R; Bottermann M; Villavicencio PM; Yan Y; Xie Z; Warner JE; Ellis-Pugh JR; Kalyuzhniy O; Liguori A; Willis JR; Menis S; Rämisch S; Eskandarzadeh S; Kubitz M; Tingle R; Phelps N; Groschel B; Himansu S; Carfi A; Kirsch KH; Weldon SR; Nair U; Schief WR; Batista FD
    Sci Immunol; 2024 May; 9(95):eadn0622. PubMed ID: 38753808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
    Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
    Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
    Steichen JM; Kulp DW; Tokatlian T; Escolano A; Dosenovic P; Stanfield RL; McCoy LE; Ozorowski G; Hu X; Kalyuzhniy O; Briney B; Schiffner T; Garces F; Freund NT; Gitlin AD; Menis S; Georgeson E; Kubitz M; Adachi Y; Jones M; Mutafyan AA; Yun DS; Mayer CT; Ward AB; Burton DR; Wilson IA; Irvine DJ; Nussenzweig MC; Schief WR
    Immunity; 2016 Sep; 45(3):483-496. PubMed ID: 27617678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.
    Leaman DP; Stano A; Chen Y; Zhang L; Zwick MB
    J Virol; 2021 Jun; 95(13):e0000521. PubMed ID: 33883221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational HIV immunogen design to target specific germline B cell receptors.
    Jardine J; Julien JP; Menis S; Ota T; Kalyuzhniy O; McGuire A; Sok D; Huang PS; MacPherson S; Jones M; Nieusma T; Mathison J; Baker D; Ward AB; Burton DR; Stamatatos L; Nemazee D; Wilson IA; Schief WR
    Science; 2013 May; 340(6133):711-6. PubMed ID: 23539181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.
    Escolano A; Steichen JM; Dosenovic P; Kulp DW; Golijanin J; Sok D; Freund NT; Gitlin AD; Oliveira T; Araki T; Lowe S; Chen ST; Heinemann J; Yao KH; Georgeson E; Saye-Francisco KL; Gazumyan A; Adachi Y; Kubitz M; Burton DR; Schief WR; Nussenzweig MC
    Cell; 2016 Sep; 166(6):1445-1458.e12. PubMed ID: 27610569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
    Shen X; Basu R; Sawant S; Beaumont D; Kwa SF; LaBranche C; Seaton KE; Yates NL; Montefiori DC; Ferrari G; Wyatt LS; Moss B; Alam SM; Haynes BF; Tomaras GD; Robinson HL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.
    Galkin A; Chen Y; Guenaga J; O'Dell S; Acevedo R; Steinhardt JJ; Wang Y; Wilson R; Chiang CI; Doria-Rose N; Grishaev AV; Mascola JR; Li Y
    J Immunol; 2020 Mar; 204(6):1543-1561. PubMed ID: 32066595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the N332-supersite of the HIV-1 envelope for vaccine design.
    Moyo T; Kitchin D; Moore PL
    Expert Opin Ther Targets; 2020 Jun; 24(6):499-509. PubMed ID: 32340497
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.
    Cottrell CA; Hu X; Lee JH; Skog P; Luo S; Flynn CT; McKenney KR; Hurtado J; Kalyuzhniy O; Liguori A; Willis JR; Landais E; Raemisch S; Chen X; Baboo S; Himansu S; Diedrich JK; Duan H; Cheng C; Schiffner T; Bader DLV; Kulp DW; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Sincomb T; Kubitz M; Mullen TM; Yates JR; Paulson JC; Mascola JR; Alt FW; Briney B; Sok D; Schief WR
    Sci Transl Med; 2024 May; 16(748):eadn0223. PubMed ID: 38753806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice.
    Melzi E; Willis JR; Ma KM; Lin YC; Kratochvil S; Berndsen ZT; Landais EA; Kalyuzhniy O; Nair U; Warner J; Steichen JM; Kalyuzhniy A; Le A; Pecetta S; Perez M; Kirsch K; Weldon SR; Falcone S; Himansu S; Carfi A; Sok D; Ward AB; Schief WR; Batista FD
    Immunity; 2022 Nov; 55(11):2168-2186.e6. PubMed ID: 36179690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.
    Longo NS; Sutton MS; Shiakolas AR; Guenaga J; Jarosinski MC; Georgiev IS; McKee K; Bailer RT; Louder MK; O'Dell S; Connors M; Wyatt RT; Mascola JR; Doria-Rose NA
    J Virol; 2016 Dec; 90(23):10574-10586. PubMed ID: 27654288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.